Evidence map›Paper›PMID 35570159›Full record

ArticleOphthalmology2022

Femtosecond Laser-Assisted Cataract Surgery: A Report by the American Academy of Ophthalmology.

Charles C Lin, Jennifer R Rose-Nussbaumer, Zaina N Al-Mohtaseb, Seth M Pantanelli, Walter Allan Steigleman, Kathryn M Hatch, Marcony R Santhiago, Stephen J Kim, Julie M Schallhorn

Open access · greenAbstract read
In one paragraph

Article in Ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Update on Femtosecond Laser-Assisted Cataract Surgery: A Review.Clinical ophthalmology (Auckland, N.Z.) · 2024
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 2 countries.

Charles C LinDepartment of Ophthalmology, Byers Eye Institute, Stanford University, Stanford, California.
Jennifer R Rose-NussbaumerDepartment of Ophthalmology, Byers Eye Institute, Stanford University, Stanford, California; Francis I. Proctor Foundation, University of California, San Francisco.
Zaina N Al-MohtasebDepartment of Ophthalmology, Baylor College of Medicine, Houston, Texas.
Seth M PantanelliDepartment of Ophthalmology, Penn State College of Medicine, Hershey, Pennsylvania.
Walter Allan SteiglemanDepartment of Ophthalmology, University of Florida College of Medicine, Gainesville, Florida.
Kathryn M HatchDepartment of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts.
Marcony R SanthiagoDepartment of Ophthalmology, University of Sao Paulo, Sao Paulo, Brazil.
Stephen J KimDepartment of Ophthalmology, Vanderbilt University School of Medicine, Nashville, Tennessee.
Julie M SchallhornDepartment of Ophthalmology, University of California, San Francisco, California.
Smith-Kettlewell Eye Research Institute · USBaylor College of Medicine · USMassachusetts Eye and Ear Infirmary · USPenn State Milton S. Hershey Medical Center · USUniversidade de São Paulo · BRUniversity of California, San Francisco · USUniversity of Florida · USVanderbilt University · US

Funding

Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
Descemet Endothelial Thickness Comparison Trial (DETECT)UG1EY030417 · NEI · STANFORD UNIVERSITY · PI ROSE-NUSSBAUMER, JENNIFER · 2021 to 2025
$5.7M
Steroids and Cross-linking for Ulcer Treatment (SCUT II)UG1EY028518 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIETMAN, THOMAS M, ROSE-NUSSBAUMER, JENNIFER · 2019 to 2023
$3.9M
NEI NIH HHS P30 EY026877NEI NIH HHS UG1 EY028518NEI NIH HHS UG1 EY030417
6 · The paper itself

Abstract

purposeTo evaluate refractive outcomes, safety, and cost-effectiveness of femtosecond laser-assisted cataract surgery (FLACS) compared with phacoemulsification cataract surgery (PCS).

methodsA PubMed search of FLACS was conducted in August 2020. A total of 727 abstracts were reviewed and 33 were selected for full-text review. Twelve articles met inclusion criteria and were included in this assessment. The panel methodologist assigned a level of evidence rating of I to all 12 studies.

resultsNo significant differences were found in mean uncorrected distance visual acuity, best-corrected distance visual acuity, or the percentage of eyes within ± 0.5 and ± 1 diopter of intended refractive target between FLACS and PCS. Intraoperative and postoperative complication rates were similar between the 2 groups, and most studies showed no difference in endothelial cell loss between FLACS and PCS at various time points between 1 and 6 months. In large randomized controlled studies in the United Kingdom and France, FLACS was less cost-effective than PCS.

conclusionsBoth FLACS and PCS have similar excellent safety and refractive outcomes. At this time, one technique is not superior to the other, but economic analyses performed in some populations have shown that FLACS is less cost-effective.

Indexed as

CataractCataract ExtractionLaser TherapyOphthalmologyPhacoemulsificationHumansLasers

Identifiers

PMID35570159
PMCPMC10123052
OpenAlexW4280561694

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.